Skip to Content

STO 125 (Carbidopa, Entacapone and Levodopa 31.25 mg / 200 mg / 125 mg)

Pill with imprint STO 125 is Red, Elliptical / Oval and has been identified as Carbidopa, Entacapone and Levodopa 31.25 mg / 200 mg / 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for STO 125

Carbidopa, entacapone and levodopa 31.25 mg / 200 mg / 125 mg STO 125
Carbidopa, entacapone and levodopa 31.25 mg / 200 mg / 125 mg STO 125
Carbidopa, entacapone and levodopa 31.25 mg / 200 mg / 125 mg STO 125

Carbidopa, Entacapone and Levodopa

Imprint
STO 125
Strength
31.25 mg / 200 mg / 125 mg
Color
Red
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-8303

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.